These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30465164)

  • 1. Combination index of the concentration and in vivo antagonism activity of racemic warfarin and its metabolites to assess individual drug responses.
    Kobayashi S; Ishii K; Yamada Y; Ryu E; Hashizume J; Nose S; Hara T; Nakashima M; Ohyama K
    J Thromb Thrombolysis; 2019 Apr; 47(3):467-472. PubMed ID: 30465164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study.
    Gemmati D; Burini F; Talarico A; Fabbri M; Bertocco C; Vigliano M; Moratelli S; Cuneo A; Serino ML; Avato FM; Tisato V; Gaudio RM
    PLoS One; 2016; 11(9):e0162084. PubMed ID: 27606428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Warfarin Metabolites in Patients Following Cardiac Valve Implantation: A Contribution of Clinical and Genetic Factors.
    Bryk A; Wypasek E; Awsiuk M; Maj D; Undas A
    Cardiovasc Drugs Ther; 2015 Jun; 29(3):257-64. PubMed ID: 25986145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of warfarin and 7-hydroxywarfarin enantiomers by high-performance liquid chromatography with ultraviolet detection.
    Miura M; Okuyama S; Kato S; Kagaya H; Murata A; Komatsuda A; Wakui H; Sawada K
    Ther Drug Monit; 2011 Feb; 33(1):108-14. PubMed ID: 21157402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of warfarin enantiomers and its metabolite in human plasma by column-switching high-performance liquid chromatography with chiral separation.
    Uno T; Niioka T; Hayakari M; Sugawara K; Tateishi T
    Ther Drug Monit; 2007 Jun; 29(3):333-9. PubMed ID: 17529891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cellular system for quantitation of vitamin K cycle activity: structure-activity effects on vitamin K antagonism by warfarin metabolites.
    Haque JA; McDonald MG; Kulman JD; Rettie AE
    Blood; 2014 Jan; 123(4):582-9. PubMed ID: 24297869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of unbound warfarin enantiomers in human plasma and 7-hydroxywarfarin in human urine by chiral stationary-phase liquid chromatography with ultraviolet or fluorescence and on-line circular dichroism detection.
    Takahashi H; Kashima T; Kimura S; Muramoto N; Nakahata H; Kubo S; Shimoyama Y; Kajiwara M; Echizen H
    J Chromatogr B Biomed Sci Appl; 1997 Nov; 701(1):71-80. PubMed ID: 9389340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of warfarin enantiomers and hydroxylated metabolites in human blood plasma by liquid chromatography with achiral and chiral separation.
    Locatelli I; Kmetec V; Mrhar A; Grabnar I
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(2):191-8. PubMed ID: 15734158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel multi-mode ultra performance liquid chromatography-tandem mass spectrometry assay for profiling enantiomeric hydroxywarfarins and warfarin in human plasma.
    Jones DR; Boysen G; Miller GP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(15-16):1056-62. PubMed ID: 21470921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of the association of pharmacokinetic and pharmacodynamic parameters of warfarin with the dose in patients on long-term anticoagulation.
    Kulkarni UP; Swar BD; Karnad DR; Davis S; Patwardhan AM; Kshirsagar NA; Gogtay NJ
    Br J Clin Pharmacol; 2008 May; 65(5):787-90. PubMed ID: 18294321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to use warfarin assays in patient management: analysis of 437 warfarin measurements in a clinical setting.
    Lee K; Woo HI; Bang OY; On YK; Kim JS; Lee SY
    Clin Pharmacokinet; 2015 May; 54(5):517-25. PubMed ID: 25466603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous measurement of S-warfarin, R-warfarin, S-7-hydroxywarfarin and R-7-hydroxywarfarin in human plasma by liquid chromatography-tandem mass spectrometry.
    Zuo Z; Wo SK; Lo CM; Zhou L; Cheng G; You JH
    J Pharm Biomed Anal; 2010 Jun; 52(2):305-10. PubMed ID: 20133101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
    Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
    Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warfarin and vitamin K compete for binding to Phe55 in human VKOR.
    Czogalla KJ; Biswas A; Höning K; Hornung V; Liphardt K; Watzka M; Oldenburg J
    Nat Struct Mol Biol; 2017 Jan; 24(1):77-85. PubMed ID: 27941861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The characterization of potent novel warfarin analogs.
    Kerr JS; Li HY; Wexler RS; Robinson AJ; Robinson CS; Boswell GA; Krauthauser C; Harlow PP
    Thromb Res; 1997 Oct; 88(2):127-36. PubMed ID: 9361366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereospecific fluorescence high-performance liquid chromatographic analysis of warfarin and its metabolites in plasma and urine.
    Banfield C; Rowland M
    J Pharm Sci; 1984 Oct; 73(10):1392-6. PubMed ID: 6502487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the relative potency of (S)- and (R)-warfarin with a new PK-PD model, in relation to VKORC1 genotypes.
    Ferrari M; Pengo V; Barolo M; Bezzo F; Padrini R
    Eur J Clin Pharmacol; 2017 Jun; 73(6):699-707. PubMed ID: 28382498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High intra- and inter-individual variability of plasma vitamin K concentrations in patients with atrial fibrillation under warfarin therapy.
    Kim YE; Woo HI; On YK; Kim JS; Lee SY
    Eur J Clin Nutr; 2015 Jun; 69(6):703-6. PubMed ID: 25828628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices.
    Couris R; Tataronis G; McCloskey W; Oertel L; Dallal G; Dwyer J; Blumberg JB
    Int J Vitam Nutr Res; 2006 Mar; 76(2):65-74. PubMed ID: 16941417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regioselectivity significantly impacts microsomal glucuronidation efficiency of R/S-6, 7-, and 8-hydroxywarfarin.
    Kim SY; Jones DR; Kang JY; Yun CH; Miller GP
    Xenobiotica; 2019 Apr; 49(4):397-403. PubMed ID: 29543105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.